WET AGE RELATED MACULAR DEGENERATION
Clinical trials for WET AGE RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new WET AGE RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for WET AGE RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy could end frequent eye injections for wet AMD
Disease control Not yet recruitingThis study tests a gene therapy called EXG202 for people with wet age-related macular degeneration (nAMD). The goal is to see if a single injection can safely deliver a protein that blocks harmful blood vessel growth, potentially reducing the need for repeated eye injections. The…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Guangzhou Jiayin Biotech Ltd • Aim: Disease control
Last updated May 17, 2026 05:50 UTC
-
Elderly AMD patients to test new home Eye-Tracking tool
Knowledge-focused Not yet recruitingThis study looks at how willing elderly patients with age-related macular degeneration (AMD) are to use a new web-based system that tracks their eye movements at home. The system is designed to be easy for older adults to use, with simple navigation and both visual and audio feed…
Matched conditions: WET AGE RELATED MACULAR DEGENERATION
Sponsor: Tan Tock Seng Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC